Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS

Luo S, Xu X, Ye X, Zhu X, Wu C, Chen D, Jin J, Zheng Y, Zheng M, Huang J

OncoTargets and Therapy 2020, 13:10143-10148

Published Date: 9 October 2020